Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00226694 · ClinicalTrials.gov registry record · NA
Alcohol and Gender Effects on Stress Circuit Function
A NA study, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT00226694 is a NA study that has completed, run by University of Cincinnati. The registered enrollment target is 96 participants.
The verdict
NCT00226694, a NA study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
The purpose of this study is to look at the stress hormone response to medication-induced stress and a placebo (an inactive compound) in non-drinking, recovering male and female alcoholics, with a specific emphasis on the differences between men and women in the two recovering alcoholic groups.
Interventions
- OTHER Placebo
- DRUG Citalopram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2003-09 |
| Est. Completion | 2012-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00226694
The ClinicalTrials.gov registry entry for NCT00226694 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00226694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00226694 about?
NCT00226694 is a clinical study titled "Alcohol and Gender Effects on Stress Circuit Function". The purpose of this study is to look at the stress hormone response to medication-induced stress and a placebo (an inactive compound) in non-drinking, recovering male and female alcoholics, with a specific emphasis on the differences between men and women in the two recovering alcoholic groups.
What is the current status of trial NCT00226694?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2003-09. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00226694?
The interventions under investigation include: Placebo (OTHER), Citalopram (DRUG).
Who is sponsoring clinical trial NCT00226694?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.